Indomethacin and beta-blockers in hypertension

Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes.

Immunotherapy advances·2022

Efficacy of an information system addressed to nursing staff for diminishing contaminated blood cultures: a blind clinical trial.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2019

In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions.

Human molecular genetics·2017

Higher vitamin D levels in HIV-infected out-patients on treatment with boosted protease inhibitor monotherapy.

HIV medicine·2013

Inertial attitude control of a bat-like morphing-wing air vehicle.

Bioinspiration & biomimetics·2012

Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.

Transplantation proceedings·2012

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Utilization patterns of second-generation androgen receptor pathway inhibitors as first-line therapy for prostate cancer in the United States.

Prostate cancer and prostatic diseases·2026

Progress on novel compounds for the treatment of bone metabolism-related disorders: focus on osteoporosis and beyond.

Frontiers in chemistry·2026

Clinical Approach to Impulse Control-Related Behavioral Disorders in Parkinson's Disease: A Scoping Review.

Movement disorders clinical practice·2026

Prescribing and monitoring of riluzole in amyotrophic lateral sclerosis: a retrospective cohort study from Health New Zealand - Te Whatu Ora Waitaha Canterbury.

The New Zealand medical journal·2026

Researchers struggle to improve nonopioid pain drugs.

Science (New York, N.Y.)·2026

Patterns and Trends in Vasoactive Medication Use in Patients With Pulmonary Arterial Hypertension Presenting With Shock.

Pulmonary circulation·2026

Related Experiment Videos

Indomethacin and beta-blockers in hypertension

Related Concept Videos

Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes.

Efficacy of an information system addressed to nursing staff for diminishing contaminated blood cultures: a blind clinical trial.

In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions.

Higher vitamin D levels in HIV-infected out-patients on treatment with boosted protease inhibitor monotherapy.

Inertial attitude control of a bat-like morphing-wing air vehicle.

Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Utilization patterns of second-generation androgen receptor pathway inhibitors as first-line therapy for prostate cancer in the United States.

Progress on novel compounds for the treatment of bone metabolism-related disorders: focus on osteoporosis and beyond.

Clinical Approach to Impulse Control-Related Behavioral Disorders in Parkinson's Disease: A Scoping Review.

Prescribing and monitoring of riluzole in amyotrophic lateral sclerosis: a retrospective cohort study from Health New Zealand - Te Whatu Ora Waitaha Canterbury.

Researchers struggle to improve nonopioid pain drugs.

Patterns and Trends in Vasoactive Medication Use in Patients With Pulmonary Arterial Hypertension Presenting With Shock.

Related Experiment Videos

Indomethacin and beta-blockers in hypertension

Related Concept Videos

Related Articles